Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

Your search for ‘Goodwin Procter LLP’ returned 4,546 results

Use advanced search filters to refine your search

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    SEC Proposes Amendments To Exchange Act Rule 15b9-1—Is FINRA Taking Over The Lease At 100 F Street NE?

    Back in April 2022, we wrote about the SEC killing the Dealer/Trader distinction. We also noted then that it would come as no surprise to see the SEC re-propose amendments...
    United StatesCorporate/Commercial Law
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    SEC Staff Issues No-Action Letter Addressing Form S-3 Eligibility For Voluntary Filers

    The SEC Division of Corporation Finance has issued guidance clarifying Form S-3 eligibility requirements for companies with brief interruptions in their Exchange Act reporting obligations. This no-action letter addresses a nuanced scenario where an issuer maintained continuous reporting despite a temporary suspension of mandatory filing requirements under Section 15(d).
    United StatesCorporate/Commercial Law
Goodwin Procter LLP
Goodwin Procter LLP
  • Article

    Texas Legislation Regulating Proxy Advisory Firms Effective September 1st

    On June 21, 2025, the Governor of Texas signed Texas Senate Bill 2337 ("S.B. 2337"), Relating to the regulation of the provision of proxy advisory services, into law. S.B. 2337...
    United StatesCorporate/Commercial Law
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    Who Gets Overtime Pay Under New DOL Rule?

    The DOL recently released a rule that will extend eligibility for overtime pay to millions of salaried workers.
    United StatesEmployment and HR
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    Acting Comptroller Of The Currency Discusses OCC's Regulatory Agenda

    In recent remarks delivered at the U.S. Chamber of Commerce Capital Markets Summit, Acting Comptroller of the Currency...
    United StatesFinance and Banking
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    CFPB Brings Clarity To Earned Wage Access Products

    The Consumer Financial Protection Bureau (CFPB) issued an advisory opinion on December 23, 2025, that resolves significant regulatory uncertainty surrounding whether earned wage access (EWA) products and are "credit" for purposes of Regulation Z, the Truth in Lending Act's (TILA) implementing regulation.
    United StatesFinance and Banking
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    CFPB Dismisses Deposit Account Lawsuit Against National Retailer And Fintech Company

    The Consumer Financial Protection Bureau voluntarily dismissed its lawsuit with prejudice against a major retailer and a fintech company in the District of Minnesota.
    United StatesFinance and Banking
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    CFPB Enters Into Consent Order With Mortgage Servicer Resolving Allegations Of Improper Foreclosure Practices

    On August 21, 2024, the Consumer Financial Protection Bureau (CFPB)​ announced​ that it entered into a consent order with a​ Florida-based mortgage servicer...
    United StatesFinance and Banking
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    CFPB Files Suit Against Bank For Alleged Savings Account Interest Rate Freezing

    On January 14, 2025, the CFPB announced ​that it had filed a complaint against a large national bank​​ for alleged ​violations of the Consumer Financial Protection Act (CFPA), the Truth in Savings Act (TISA)...
    United StatesFinance and Banking
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    CFPB Orders Money Exchange Company To Pay $2.5 Million Over Remittance Practices

    On January 30, 2025, the Consumer Financial Protection Bureau (CFPB) announced that it had entered into a consent order with an international remittance company regarding the company's use of deceptive advertising...
    United StatesFinance and Banking
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    CFPB Revises Supervisory Appeals Process

    On February 16, 2024, the Consumer Financial Protection Bureau (CFPB or Bureau) announced that it is updating its internal supervisory appeals process for institutions...
    United StatesFinance and Banking
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    DOJ Reaches Settlement Over Bank's Alleged Redlining

    On May 31, 2023, the United States Department of Justice (DOJ), announced that it had entered into a settlement with a Philadelphia based bank ..
    United StatesFinance and Banking
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    FINRA Proposes To Publicly Identify "Restricted Firms" On BrokerCheck

    BrokerCheck is the database through which FINRA publishes licensing, registration, and disciplinary history of brokerage industry firms and their personnel.
    United StatesFinance and Banking
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    FINRA Reminds Firms Of Trusted Contact Person Requirement, Benefits, And Related Effective Practices

    FINRA remains very focused on preventing financial exploitation of seniors and other investors. Firms can expect to see senior investor protection as a key area of focus in the forthcoming 2023 Report...
    United StatesFinance and Banking
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    Global Capital Flows Panel (Video)

    Global Capital Flows Panel (Video)
    United StatesFinance and Banking
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    OCC Clarifies Fee Authority And Preemption Under The National Bank Act

    In April 2026, the Office of the Comptroller of the Currency issued two coordinated interim actions addressing national banks’ authority to impose certain fees. 
    United StatesFinance and Banking
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    Amgen Releases 2022 Biosimilar Trends Report

    On October 12, 2022, Amgen released its 2022 Biosimilar Trends Report. Since we posted on Amgen's report preview in July, the total number of biosimilars that have been approved in the United States...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    Biogen Announces EMA Acceptance Of Tocilizumab Biosimilar Application

    Biogen Inc. ("Biogen") recently announced that the European Medicines Agency (EMA) has accepted the marketing authorization application for BIIB800 (BAT1806)...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    Biosimilar Clinical Trial Updates

    Big Molecule Watch monitors for biosimilar clinical trial results.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    Biosimilar Deal Watch: Formycon/ATHOS, Fresenius/mAbxience/Ivenix, And Intas/Axantia

    It has been a busy last few weeks for biosimilar developers, with multiple deals announced.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Showing 901–920 of 4546 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics